1. Van Cutsem E, lang I, Folprecht G, et al. Cetuximab plus FOLFIRI in the treatment of metastatic colorectal cancer (mCRC): The influence of KRAS and BRAF biomarkers on outcome: Updated data from the CRYSTAL trial. Presented at: the 2010 Gastrointestinal Cancers Sympsium. Abstract 281.
2. Genetic prognostic and predictive markers in colorectal cancer;Walther;Nat Rev Cancer,2009
3. The use of molecular markers in the diagnosis and treatment of colorectal cancer;Tejpar;Best Pract Res Clin Gastroenterol,2007
4. Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies;Wong;J Clin Oncol,2008
5. Weinberg, R. Growth factors, receptors and cancer. In: The Biology of Cancer. 119-58.